Psychometric Evaluation of the Celiac Disease Symptom Diary 2.1© Using Data from the Virtual Celiac Symptoms Study
This evaluation provides evidence to support the use of CDSD 2.1 in clinical trials as a reliable and responsive measure of CeD symptom severity.
Authors
- Daniel A. Leffler (ORCID: https://orcid.org/0000-0002-0750-3386)
- Muna J. Tahir (ORCID: https://orcid.org/0000-0001-9611-2506)
- Lisa M. Meckley (ORCID: https://orcid.org/0000-0002-4791-4294)
- Nicholas Rockwood (ORCID: https://orcid.org/0000-0001-5931-183X)
- LORI MCLEOD
- sonal ghura (ORCID: https://orcid.org/0009-0004-8615-9297)
- Edwin Liu
- Dawn Adams
- Ragy Saad
- Marilyn Geller
Institutions
- Beth Israel Deaconess Medical Center (US)
- Children's Hospital Colorado (US)
- RTI Health Solutions (US)
- Takeda (United States) (US)
- Vanderbilt University Medical Center (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Patient Related Outcome Measures
- Published
- 2026-02-01
- DOI
- https://doi.org/10.2147/prom.s553006
- Primary Topic
- Celiac Disease Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- United European Gastroenterology